STOCK TITAN

XWELL, Inc. - XWEL STOCK NEWS

Welcome to our dedicated page for XWELL news (Ticker: XWEL), a resource for investors and traders seeking the latest updates and insights on XWELL stock.

XWELL, Inc. (Nasdaq: XWEL) is a premier global wellness holding company dedicated to delivering health and wellness services to travelers. The company's flagship brand, XpresSpa, boasts the title of the largest airport spa company globally, with 57 locations across 23 airports. XpresSpa offers a range of premium spa services tailored to the needs of busy travelers, including massages, nail services, skincare treatments, and exclusive travel products.

Alongside XpresSpa, XWELL operates the Treat brand, which focuses on travel health and wellness by offering spa services at airports. The company also runs XpresTest, a segment providing COVID-19 screening and diagnostic testing in collaboration with the CDC. Additionally, XWELL’s portfolio includes Naples Wax Center, known for its high-performing locations offering face and body waxing services, and HyperPointe, which provides specialized marketing services.

In recent developments, XWELL has introduced automated beauty and wellness experiences, such as the Clockwork MiNiCURE, which delivers express manicures through advanced robotic technology. This innovation is part of XWELL’s commitment to enhancing customer experiences and operational efficiency. The company has also expanded its wellness services with automated massage chairs and IV hydration drip therapy, aiming to boost revenue and provide high-margin services.

Financially, XWELL had cash and cash equivalents of $8.4 million and marketable securities worth $14.6 million as of December 31, 2023. Despite a challenging year with total revenue of $30.1 million and notable non-cash goodwill impairment charges, the company remains focused on operational efficiency and revenue growth through new service offerings and strategic partnerships.

Strategically, XWELL continues to enhance its service offerings and expand its global footprint, including recent openings in Abu Dhabi and planned expansions in key locations such as New York City's Penn Station. The company’s commitment to public health is evident through its TGS program, aimed at expanding biosecurity infrastructure with support from the CDC.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
management
-
Rhea-AI Summary
XWELL, Inc. reports first quarter 2023 results with a 70% increase in revenue for XpresSpa business. General and administrative expenses decreased by 12.7% sequentially and 40.2% from the previous year. XWELL plans to open new XpresSpa locations in Philadelphia and Abu Dhabi. Valerie Lightfoot appointed as Chief Financial Officer. XWELL focuses on driving growth through organic and external investments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
XWELL, Inc. will release its first quarter 2023 financial results on May 15, 2023, after the market close. A webcast and conference call will follow at 5:00 p.m. ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

XWELL, Inc. (Nasdaq: XWEL) announced its financial results for the year ending December 31, 2022, reporting total revenue of $55.9 million, a decrease from $73.7 million in 2021. The net loss attributable to common shareholders was $32.8 million, compared to a net income of $3.3 million the previous year. Key initiatives include the opening of new XpresSpa locations and partnerships to integrate innovative health technologies. The company’s operational adjustments led to a reduction in cash operating costs and the closure of underperforming locations. Financial metrics indicate a working capital of $36.4 million with no long-term debt. XWELL continues to focus on growth in wellness services at airports, expanding its biosurveillance program, and enhancing retail strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.82%
Tags
-
Rhea-AI Summary

XWELL, Inc. (Nasdaq: XWEL) will announce its fiscal year 2022 financial results on April 17, 2023, after market close, followed by a webcast and conference call at 5:00 PM ET. Interested investors are encouraged to listen via the webcast due to limited phone line capacity.

The Company operates four brands: XpresSpa, a leader in airport wellness services with 35 locations; Treat, a travel health brand; XpresCheck, providing COVID-19 testing; and HyperPointe, a digital healthcare analytics firm. XWELL emphasizes the importance of health and wellness solutions for travelers.

Forward-looking statements are included regarding future performance expectations, which are not guaranteed and involve risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
-
Rhea-AI Summary

XWELL plans to submit a Form 12b-25 to the SEC for its Annual Report on Form 10-K for the fiscal year ending December 31, 2022. The company requires extra time to assess a non-cash impairment charge for Q4 2022, granting an additional 15 days for its audit. Total revenue for 2022 is projected at $56 million, with a gross profit margin decline from 44% to 22%. Costs rose to $44 million, and general administrative expenses increased to $31 million. Despite these challenges, XWELL opened five new XpresSpa locations and reduced cash operating costs through the closure of underperforming sites. The 2022 Form 10-K is expected by April 17, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

XWELL has launched a groundbreaking beauty experience at airports by introducing Clockwork’s AI-powered manicure robots in its XpresSpa location at JFK, making it the first airport globally to offer this service. The robots, known as Clockwork MiNiCURE, provide efficient and high-quality manicures in under 10 minutes. XWELL plans to expand this innovative service by deploying up to 25 robots across its 31 spa locations soon. This partnership showcases XWELL's commitment to enhancing wellness offerings for travelers while embracing cutting-edge technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of XWELL (XWEL)?

The current stock price of XWELL (XWEL) is $1.6 as of December 20, 2024.

What is the market cap of XWELL (XWEL)?

The market cap of XWELL (XWEL) is approximately 8.1M.

What services does XWELL, Inc. provide?

XWELL, Inc. offers premium spa services, COVID-19 testing, waxing services, and automated beauty treatments through its brands like XpresSpa, Treat, and Naples Wax Center.

Where can I find XpresSpa locations?

XpresSpa has 57 locations in 23 airports globally, providing tailored spa services to travelers.

What is the Clockwork MiNiCURE?

The Clockwork MiNiCURE is an express manicure service using advanced robotics to deliver high-quality nail polish within minutes.

How is XWELL contributing to public health?

XWELL’s TGS program, in partnership with the CDC, involves biosecurity infrastructure for pathogen detection and biosurveillance at airports.

What are the financial highlights of XWELL, Inc. for 2023?

As of December 31, 2023, XWELL reported $8.4 million in cash, $14.6 million in marketable securities, and total revenue of $30.1 million.

What new services has XWELL launched recently?

XWELL has introduced automated massage chairs and IV hydration drip therapy services to enhance its wellness offerings and increase revenue.

What is XpresTest?

XpresTest is a segment of XWELL providing COVID-19 screening and diagnostic testing in partnership with the CDC.

Where are the Naples Wax Center locations?

Naples Wax Center operates three locations in Florida, offering face and body waxing services and skincare products.

How does XWELL plan to expand its services?

XWELL plans to expand its wellness centers, including new locations in Abu Dhabi and New York City's Penn Station, and introduce new automated services.

What is the TGS program?

The TGS program is a biosecurity initiative led by XWELL in collaboration with the CDC to detect and monitor pathogens at airports.

XWELL, Inc.

Nasdaq:XWEL

XWEL Rankings

XWEL Stock Data

8.09M
4.76M
9.65%
17.55%
1.37%
Diagnostics & Research
Services-personal Services
Link
United States of America
NEW YORK